Molecular signaling network complexity is correlated with cancer patient survivability
- PMID: 22615392
- PMCID: PMC3384193
- DOI: 10.1073/pnas.1201416109
Molecular signaling network complexity is correlated with cancer patient survivability
Abstract
The 5-y survival for cancer patients after diagnosis and treatment is strongly dependent on tumor type. Prostate cancer patients have a >99% chance of survival past 5 y after diagnosis, and pancreatic patients have <6% chance of survival past 5 y. Because each cancer type has its own molecular signaling network, we asked if there are "signatures" embedded in these networks that inform us as to the 5-y survival. In other words, are there statistical metrics of the network that correlate with survival? Furthermore, if there are, can such signatures provide clues to selecting new therapeutic targets? From the Kyoto Encyclopedia of Genes and Genomes Cancer Pathway database we computed several conventional and some less conventional network statistics. In particular we found a correlation (R(2) = 0.7) between degree-entropy and 5-y survival based on the Surveillance Epidemiology and End Results database. This correlation suggests that cancers that have a more complex molecular pathway are more refractory than those with less complex molecular pathway. We also found potential new molecular targets for drugs by computing the betweenness--a statistical metric of the centrality of a node--for the molecular networks.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- MacDonald P. Chemotherapeutic Drugs. In: Scheinemann K, Boyce AE, editors. Emergencies in Pediatric Oncology. New York: Springer; 2012. pp. 105–120.
-
- Kandalaft LE, Motz GT, Busch J, Coukos G. Angiogenesis and the tumor vasculature as antitumor immune modulators: The role of vascular endothelial growth factor and endothelin. Curr Top Microbiol Immunol. 2011;344:129–148. - PubMed
-
- Marshall E. Cancer research and the $90 billion metaphor. Science. 2011;331:1540–1541. - PubMed
-
- Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet. 2002;360:1131–1135. - PubMed
-
- Ellison LF, Gibbons L. Survival from cancer—Up-to-date predictions using period analysis. Health Rep. 2006;17:19–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
